Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 2/2010

01-06-2010 | Review Article

Leiomyosarcoma of the urinary bladder presenting as life threatening gross hematuria

Authors: Thomas Nelius, J. Stevens, C. Samathanam, S. Filleur

Published in: Medical Oncology | Issue 2/2010

Login to get access

Abstract

Leiomyosarcomas are a relatively rare tumor entity encountered within the urinary bladder. There are just over 100 cases reported in the medical literature. Herein, we describe a case of leiomyosarcoma presenting initially as a urinary tract infection with lower abdominal pain. A life threatening episode of gross hematuria guided to the final diagnosis and treatment. Due to the rarity of this malignancy, we present this case including a review of the existing literature relative to the diagnosis and treatment.
Literature
1.
Fulcher J. Leiomyosarcoma of the urinary bladder. J Okla State Med Assoc. 1948;41(3):82.PubMed
2.
Bergman RT, Kugel AI. Leiomyosarcoma of the urinary bladder. Urol Cutaneous Rev. 1950;54(2):65–7. illust.PubMed
3.
Seo IS, Clark SA, McGovern FD, Clark DL, Johnson EH. Leimyosarcoma of the urinary bladder. 13 years after cyclophosphamide therapy for Hodgkin’s disease. Cancer. 1985;55(7):1597–603.CrossRefPubMed
4.
Labanaris AP, Zugor V, Meyer B, Nutzel R, Helmus S, Labanaris PG, et al. Urinary bladder leiomyosarcoma in adults. Int Urol Nephrol. 2008;40(2):311–6.CrossRefPubMed
5.
Berkmen F, Celebioglu AS. Adult genitourinary sarcomas: a report of seventeen cases and review of the literature. J Exp Clin Cancer Res. 1997;16(1):45–8.PubMed
6.
Dahm P, Gschwend JE. Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol. 2003;44(6):672–81.CrossRefPubMed
7.
Mills SE, Bova GS, Wick MR, Young RH. Leiomyosarcoma of the urinary bladder. A clinicopathologic and immunohistochemical study of 15 cases. Am J Surg Pathol. 1989;13(6):480–9.PubMed
8.
Russo P, Brady MS, Conlon K, Hajdu SI, Fair WR, Herr HW, et al. Adult urological sarcoma. J Urol. 1992;147(4):1032–6. discussion 6–7.PubMed
9.
Sen SE, Malek RS, Farrow GM, Lieber MM. Sarcoma and carcinosarcoma of the bladder in adults. J Urol. 1985;133(1):29–30.PubMed
10.
Venkatraman L, Goepel JR, Steele K, Dobbs SP, Lyness RW, McCluggage WG. Soft tissue, pelvic, and urinary bladder leiomyosarcoma as second neoplasm following hereditary retinoblastoma. J Clin Pathol. 2003;56(3):233–6.CrossRefPubMed
11.
Kawamura J, Sakurai M, Tsukamoto K, Tochigi H. Leiomyosarcoma of the bladder eighteen years after cyclophosphamide therapy for retinoblastoma. Urol Int. 1993;51(1):49–53.CrossRefPubMed
12.
Rowland RG, Eble JN. Bladder leiomyosarcoma and pelvic fibroblastic tumor following cyclophosphamide therapy. J Urol. 1983;130(2):344–6.PubMed
13.
Sigal SH, Tomaszewski JE, Brooks JJ, Wein A, LiVolsi VA. Carcinosarcoma of bladder following long-term cyclophosphamide therapy. Arch Pathol Lab Med. 1991;115(10):1049–51.PubMed
14.
Thrasher JB, Miller GJ, Wettlaufer JN. Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis. J Urol. 1990;143(1):119–21.PubMed
15.
Tanguay C, Harvey I, Houde M, Srigley JR, Tetu B. Leiomyosarcoma of urinary bladder following cyclophosphamide therapy: report of two cases. Mod Pathol. 2003;16(5):512–4.CrossRefPubMed
16.
Parekh DJ, Jung C, O’Conner J, Dutta S, Smith ER Jr. Leiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas. Urology. 2002;60(1):164.CrossRefPubMed
17.
Pedersen-Bjergaard J, Jonsson V, Pedersen M, Hou-Jensen K. Leiomyosarcoma of the urinary bladder after cyclophosphamide. J Clin Oncol. 1995;13(2):532–3.PubMed
18.
Rosser CJ, Slaton JW, Izawa JI, Levy LB, Dinney CP. Clinical presentation and outcome of high-grade urinary bladder leiomyosarcoma in adults. Urology. 2003;61(6):1151–5.CrossRefPubMed
19.
Sonobe H, Okada Y, Sudo S, Iwata J, Ohtsuki Y. Inflammatory pseudotumor of the urinary bladder with aberrant expression of cytokeratin. Report of a case with cytologic, immunocytochemical and cytogenetic findings. Acta Cytol. 1999;43(2):257–62.PubMed
20.
Mottet-Auselo N, Marsollier C, Chapuis H, Costa P, el Sandid M, Louis JF, et al. Postoperative pseudosarcomatous nodule: report of one case and review of the literature. Eur Urol. 1994;25(3):262–4.PubMed
21.
Ikegami H, Iwasaki H, Ohjimi Y, Takeuchi T, Ariyoshi A, Kikuchi M. Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 14 patients. Hum Pathol. 2000;31(3):332–40.CrossRefPubMed
22.
Wick MR, Brown BA, Young RH, Mills SE. Spindle-cell proliferations of the urinary tract. An immunohistochemical study. Am J Surg Pathol. 1988;12(5):379–89.PubMed
23.
Young RH, Proppe KH, Dickersin GR, Scully RE. Myxoid leiomyosarcoma of the urinary bladder. Arch Pathol Lab Med. 1987;111(4):359–62.PubMed
24.
Martin SA, Sears DL, Sebo TJ, Lohse CM, Cheville JC. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma. Am J Surg Pathol. 2002;26(3):292–300.CrossRefPubMed
25.
Cody HSIII, Turnbull AD, Fortner JG, Hajdu SI. The continuing challenge of retroperitoneal sarcomas. Cancer. 1981;47(9):2147–52.CrossRefPubMed
26.
De Berardinis E, Giulianelli R, Zarrelli G, De Santis C, Ginepri A, Gentile BC, et al. Leiomyosarcoma of urinary bladder: personal experience in 3 cases over a 10-year period. Arch Ital Urol Androl. 1997;69(Suppl 1):73–80.PubMed
27.
O’Sullivan B, Ward I, Catton C. Recent advances in radiotherapy for soft-tissue sarcoma. Curr Oncol Rep. 2003;5(4):274–81.CrossRefPubMed
28.
Strander H, Turesson I, Cavallin-Stahl E. A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol (Stockholm, Sweden). 2003;42(5–6):516–31.CrossRef
29.
Spiess PE, Kassouf W, Steinberg JR, Tuziak T, Hernandez M, Tibbs RF, et al. Review of the M.D. Anderson experience in the treatment of bladder sarcoma. Urol Oncol. 2007;25(1):38–45.PubMed
30.
Swartz DA, Johnson DE, Ayala AG, Watkins DL. Bladder leiomyosarcoma: a review of 10 cases with 5-year followup. J Urol. 1985;133(2):200–2.PubMed
31.
Mackenzie AR, Whitmore WF Jr, Melamed MR. Myosarcomas of the bladder and prostate. Cancer. 1968;22(4):833–44.CrossRefPubMed
32.
Ahlering TE, Weintraub P, Skinner DG. Management of adult sarcomas of the bladder and prostate. J Urol. 1988;140(6):1397–9.PubMed
33.
Dotan ZA, Tal R, Golijanin D, Snyder ME, Antonescu C, Brennan MF, et al. Adult genitourinary sarcoma: the 25-year Memorial Sloan-Kettering experience. J Urol. 2006;176(5):2033–8. discussion 8–9.CrossRefPubMed
34.
Gong MC, Bernan MF. Sarcoma of the genitourinary tract. J Urol. 1998;159(Suppl):A169.
Metadata
Title
Leiomyosarcoma of the urinary bladder presenting as life threatening gross hematuria
Authors
Thomas Nelius
J. Stevens
C. Samathanam
S. Filleur
Publication date
01-06-2010
Publisher
Springer US
Published in
Medical Oncology / Issue 2/2010
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-009-9248-2

Other articles of this Issue 2/2010

Medical Oncology 2/2010 Go to the issue

Original Paper

Aspirin inhibits ErbB2 to induce apoptosis in cervical cancer cells

Original Paper

Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinoma

Original Paper

Salvage chemotherapy with amrubicin and platinum for relapsed thymic carcinoma: experience in six cases

Original Paper

Primary colorectal lymphoma

Original Paper

New targets of PS-341: BAFF and APRIL

Original Paper

The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits